HealthCor Management as of June 30, 2019
Portfolio Holdings for HealthCor Management
HealthCor Management holds 51 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Neurocrine Biosciences (NBIX) | 7.8 | $200M | 2.4M | 84.43 | |
| Humana (HUM) | 6.6 | $171M | 645k | 265.30 | |
| Bristol Myers Squibb Call Option (BMY) | 4.6 | $119M | 2.6M | 45.35 | |
| Edwards Lifesciences (EW) | 4.5 | $115M | 622k | 184.74 | |
| Merck & Co (MRK) | 4.2 | $108M | 1.3M | 83.85 | |
| Madrigal Pharmaceuticals (MDGL) | 4.2 | $108M | 1.0M | 104.81 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.8 | $99M | 538k | 183.38 | |
| Elanco Animal Health (ELAN) | 3.8 | $97M | 2.9M | 33.80 | |
| UnitedHealth (UNH) | 3.8 | $97M | 397k | 244.01 | |
| Abbott Laboratories (ABT) | 3.7 | $96M | 1.1M | 84.10 | |
| Nevro (NVRO) | 3.1 | $80M | 1.2M | 64.83 | |
| Danaher Corporation (DHR) | 2.8 | $73M | 508k | 142.92 | |
| Horizon Therapeutics Pub SHS | 2.6 | $67M | 2.8M | 24.06 | |
| Boston Scientific Corporation (BSX) | 2.5 | $63M | 1.5M | 42.98 | |
| Intersect Ent | 2.5 | $63M | 2.8M | 22.76 | |
| Corindus Vascular Robotics I | 2.3 | $60M | 20M | 2.98 | |
| Amarin Corp Spons Adr New | 2.3 | $59M | 3.0M | 19.39 | |
| Hca Holdings (HCA) | 2.2 | $57M | 419k | 135.17 | |
| Medtronic SHS (MDT) | 2.2 | $56M | 578k | 97.39 | |
| Align Technology (ALGN) | 2.2 | $56M | 206k | 273.70 | |
| Charles River Laboratories (CRL) | 2.0 | $52M | 364k | 141.90 | |
| Gilead Sciences (GILD) | 2.0 | $52M | 763k | 67.56 | |
| Bluebird Bio | 1.8 | $47M | 368k | 127.20 | |
| Anthem (ELV) | 1.7 | $43M | 151k | 282.21 | |
| Haemonetics Corporation (HAE) | 1.6 | $42M | 350k | 120.34 | |
| Iqvia Holdings (IQV) | 1.6 | $41M | 256k | 160.90 | |
| Viewray (VRAYQ) | 1.6 | $40M | 4.6M | 8.81 | |
| Change Healthcare | 1.5 | $39M | 2.7M | 14.60 | |
| CONMED Corporation (CNMD) | 1.5 | $39M | 455k | 85.57 | |
| Blueprint Medicines (BPMC) | 1.4 | $36M | 383k | 94.33 | |
| Alnylam Pharmaceuticals (ALNY) | 1.3 | $34M | 469k | 72.56 | |
| Alcon Ord Shs (ALC) | 1.3 | $33M | 527k | 62.05 | |
| Becton, Dickinson and (BDX) | 1.2 | $31M | 121k | 252.01 | |
| Radius Health Com New | 1.2 | $30M | 1.2M | 24.36 | |
| Clovis Oncology | 1.0 | $25M | 1.6M | 14.87 | |
| Pfizer Put Option (PFE) | 0.8 | $22M | 500k | 43.32 | |
| Myokardia | 0.7 | $18M | 351k | 50.14 | |
| D Stemline Therapeutics | 0.6 | $16M | 1.1M | 15.32 | |
| Select Medical Holdings Corporation (SEM) | 0.6 | $16M | 1.0M | 15.87 | |
| NuVasive | 0.6 | $15M | 250k | 58.54 | |
| Centene Corporation (CNC) | 0.5 | $13M | 250k | 52.44 | |
| Tenet Healthcare Corp Com New (THC) | 0.3 | $8.8M | 426k | 20.66 | |
| Personalis Ord (PSNL) | 0.3 | $8.1M | 300k | 27.15 | |
| Stryker Corporation (SYK) | 0.3 | $6.9M | 33k | 205.58 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.2 | $5.8M | 120k | 48.30 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.2 | $5.5M | 500k | 10.94 | |
| Ngm Biopharmaceuticals | 0.2 | $5.0M | 343k | 14.64 | |
| Polarityte | 0.1 | $3.3M | 575k | 5.70 | |
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $3.2M | 120k | 26.73 | |
| Wright Med Group N V Ord Shs | 0.1 | $3.0M | 100k | 29.82 | |
| Axcella Health Inc equity | 0.1 | $1.6M | 171k | 9.31 |
